Sector revisions Thermo Fisher Scientific Inc.
Equities
TMO
US8835561023
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
532.78 USD | +0.60% | +3.12% | -0.10% |
12:59pm | Nephron Research Trims Price Target on Thermo Fisher Scientific to $650 From $675 | MT |
Nov. 21 | CMB International Initiates Thermo Fisher Scientific at Buy With $670 Price Target | MT |
1m. EPS revision | 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Divergence of Estimates | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|---|
28 | |||||||||
26 | |||||||||
24 | |||||||||
31 | |||||||||
19 | |||||||||
21 | |||||||||
28 | |||||||||
17 | |||||||||
19 | |||||||||
11 | |||||||||
17 | |||||||||
25 | |||||||||
17 | |||||||||
15 | |||||||||
14 | |||||||||
18 | |||||||||
11 | |||||||||
15 | |||||||||
8 | |||||||||
8 | |||||||||
Average | 19 | ||||||||
Weighted average by Cap. | 24 |
- Stock Market
- Equities
- TMO Stock
- Sector Thermo Fisher Scientific Inc.
- Sector revisions